Alaunos Therapeutics Operating Margin 2012-2025 | TCRT

Current and historical operating margin for Alaunos Therapeutics (TCRT) over the last 10 years. The current operating profit margin for Alaunos Therapeutics as of September 30, 2025 is 0.00%.
Alaunos Therapeutics Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $0.00B $0.00B 0.00%
2024-12-31 $0.00B $-0.01B 0.00%
2024-03-31 $0.00B $-0.03B 0.00%
2023-06-30 $0.00B $-0.04B -1166.67%
2018-03-31 $0.01B $-0.06B -916.67%
2017-12-31 $0.01B $-0.05B -662.50%
2017-09-30 $0.01B $-0.05B -637.50%
2017-06-30 $0.01B $-0.05B -612.50%
2017-03-31 $0.01B $-0.17B -2087.50%
2016-12-31 $0.01B $-0.17B -2062.50%
2016-09-30 $0.01B $-0.16B -2037.50%
2016-06-30 $0.01B $-0.17B -2125.00%
2016-03-31 $0.01B $-0.05B -883.33%
2015-12-31 $0.00B $-0.12B -2975.00%
2015-09-30 $0.00B $-0.12B -6050.00%
2015-06-30 $0.00B $-0.12B -11500.00%
2015-03-31 $0.00B $-0.11B -11200.00%
2014-12-31 $0.00B $-0.04B -4400.00%
2014-09-30 $0.00B $-0.04B -4000.00%
2014-06-30 $0.00B $-0.04B 0.00%
2014-03-31 $0.00B $-0.04B 0.00%
2013-12-31 $0.00B $-0.06B 0.00%
2013-09-30 $0.00B $-0.09B 0.00%
2013-06-30 $0.00B $-0.10B 0.00%
2013-03-31 $0.00B $-0.11B 0.00%
2012-12-31 $0.00B $-0.10B 0.00%
2012-09-30 $0.00B $-0.08B 0.00%
2012-06-30 $0.00B $-0.07B 0.00%
2012-03-31 $0.00B $-0.06B 0.00%
2011-12-31 $0.00B $-0.07B 0.00%
2002-06-30 $0.00B 0 0.00%
2002-03-31 $0.00B 0 0.00%
2001-12-31 $0.00B 0 0.00%
2001-09-30 $0.00B 0 0.00%
2001-06-30 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.006B $0.000B
Alaunos Therapeutics Inc. is a clinical-stage oncology-focused cell therapy company. It focused on developing T-cell receptor therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform. Alaunos Therapeutics Inc., formerly known as Ziopharm Oncology Inc., is based in HOUSTON.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $94.091B 32.86
Takeda Pharmaceutical (TAK) Japan $55.653B 10.93
Zoetis (ZTS) United States $55.060B 19.71
BeOne Medicines - (ONC) Switzerland $37.834B 200.58
Daiichi Sankyo, - (DSNKY) Japan $36.049B 17.95
Sandoz Group AG (SDZNY) Switzerland $34.668B 0.00
United Therapeutics (UTHR) United States $20.452B 18.00
Merck (MKKGY) Germany $19.309B 11.90
Shionogi (SGIOY) Japan $17.686B 13.68
Neurocrine Biosciences (NBIX) United States $13.723B 32.93
IPSEN (IPSEY) France $13.491B 0.00
Ionis Pharmaceuticals (IONS) United States $13.455B 0.00
Orion OYJ (ORINY) Finland $11.502B 32.86
Madrigal Pharmaceuticals (MDGL) United States $11.122B 0.00
Summit Therapeutics (SMMT) United States $10.842B 0.00
Eisai (ESAIY) $8.248B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.149B 17.10
Crinetics Pharmaceuticals (CRNX) United States $5.042B 0.00
Stevanato Group S.p.A (STVN) Italy $4.764B 26.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.642B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.461B 21.18
Indivior (INDV) United States $4.376B 17.86
Corcept Therapeutics (CORT) United States $4.282B 46.26
NewAmsterdam Pharma (NAMS) Netherlands $3.580B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.386B 0.00
Hypermarcas (HYPMY) Brazil $3.148B 21.61
Catalyst Pharmaceuticals (CPRX) United States $3.073B 9.80
Dyne Therapeutics (DYN) United States $2.679B 0.00
Soleno Therapeutics (SLNO) United States $2.273B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.105B 0.00
Guardian Pharmacy Services (GRDN) United States $2.050B 39.48
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.007B 23.78
Ocular Therapeutix (OCUL) United States $1.949B 0.00
Ardelyx (ARDX) United States $1.893B 0.00
Definium Therapeutics (DFTX) United States $1.796B 0.00
Enliven Therapeutics (ELVN) United States $1.672B 0.00
Harrow (HROW) United States $1.663B 102.04
Oruka Therapeutics (ORKA) United States $1.660B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.611B 0.00
Collegium Pharmaceutical (COLL) United States $1.489B 7.37
Relay Therapeutics (RLAY) United States $1.413B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.397B 82.88
Xeris Biopharma Holdings (XERS) United States $1.221B 0.00
Evotec AG (EVO) Germany $1.215B 0.00
Savara (SVRA) United States $1.123B 0.00
Aktis Oncology (AKTS) United States $1.113B 0.00
ARS Pharmaceuticals (SPRY) United States $1.018B 0.00
Theravance Biopharma (TBPH) United States $1.005B 42.19
Cronos Group (CRON) Canada $0.958B 0.00
Xencor (XNCR) United States $0.865B 0.00
Esperion Therapeutics (ESPR) United States $0.837B 0.00
KalVista Pharmaceuticals (KALV) United States $0.814B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.804B 19.00
Nektar Therapeutics (NKTR) United States $0.775B 0.00
Bioventus (BVS) United States $0.679B 13.91
Rigel Pharmaceuticals (RIGL) United States $0.654B 5.84
Altimmune (ALT) United States $0.626B 0.00
ProKidney (PROK) United States $0.614B 0.00
Lexeo Therapeutics (LXEO) United States $0.558B 0.00
Organogenesis (ORGO) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.527B 0.00
Lyell Immunopharma (LYEL) United States $0.526B 0.00
4D Molecular Therapeutics (FDMT) United States $0.523B 0.00
Aquestive Therapeutics (AQST) United States $0.500B 0.00
Siga Technologies (SIGA) United States $0.498B 6.81
Nature's Sunshine Products (NATR) United States $0.463B 27.54
Elite Pharmaceuticals (ELTP) United States $0.451B 0.00
USANA Health Sciences (USNA) United States $0.396B 11.05
Aclaris Therapeutics (ACRS) United States $0.391B 0.00
Akebia Therapeutics (AKBA) United States $0.366B 0.00
Protara Therapeutics (TARA) United States $0.363B 0.00
Cybin (HELP) Canada $0.343B 0.00
Aldeyra Therapeutics (ALDX) United States $0.327B 0.00
Larimar Therapeutics (LRMR) United States $0.291B 0.00
Avalo Therapeutics (AVTX) United States $0.290B 0.00
Journey Medical (DERM) United States $0.286B 0.00
Profound Medical (PROF) Canada $0.282B 0.00
Relmada Therapeutics (RLMD) United States $0.281B 0.00
OmniAb (OABI) United States $0.258B 0.00
Heron Therapeutics (HRTX) United States $0.253B 0.00
Enlivex Therapeutics (ENLV) Israel $0.247B 0.00
MediWound (MDWD) Israel $0.232B 0.00
Silence Therapeutics (SLN) United Kingdom $0.231B 0.00
Achieve Life Sciences (ACHV) Canada $0.229B 0.00
Context Therapeutics (CNTX) United States $0.218B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.210B 0.00
Minerva Neurosciences (NERV) United States $0.203B 0.00
Galectin Therapeutics (GALT) United States $0.193B 0.00
Surrozen (SRZN) United States $0.189B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
AleAnna (ANNA) United States $0.172B 0.00
Century Therapeutics (IPSC) United States $0.161B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.145B 0.00
Unicycive Therapeutics (UNCY) United States $0.139B 0.00
Avita Medical (RCEL) United States $0.129B 0.00
Prelude Therapeutics (PRLD) United States $0.128B 0.00
Korro Bio (KRRO) United States $0.123B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.119B 0.00
Inhibikase Therapeutics (IKT) United States $0.118B 0.00
Karyopharm Therapeutics (KPTI) United States $0.116B 0.00
Vivani Medical (VANI) United States $0.115B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Incannex Healthcare (IXHL) Australia $0.102B 0.00
Champions Oncology (CSBR) United States $0.099B 41.95
Pyxis Oncology (PYXS) United States $0.095B 0.00
Cassava Sciences (SAVA) United States $0.094B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
PolyPid (PYPD) Israel $0.077B 0.00
HST Global (HSTC) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
Fractyl Health (GUTS) United States $0.065B 0.00
NRx Pharmaceuticals (NRXP) United States $0.064B 0.00
Dominari Holdings (DOMH) United States $0.064B 0.00
Rafael Holdings (RFL) United States $0.061B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 48.25
Acrivon Therapeutics (ACRV) United States $0.057B 0.00
Nutriband (NTRB) United States $0.057B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
BioNxt Solutions (BNXTF) Canada $0.055B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Lipocine (LPCN) United States $0.050B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Talphera (TLPH) United States $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
Plus Therapeutics (PSTV) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.031B 0.00
Wellgistics Health (WGRX) United States $0.030B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.025B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Klotho Neurosciences (KLTO) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Scienture Holdings (SCNX) United States $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Inotiv (NOTV) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.02
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Liminatus Pharma (LIMN) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Vyome Holdings (HIND) United States $0.012B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
China SXT Pharmaceuticals (SXTC) China $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00